Medications for Bipolar Disorder (BPD)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Bipolar Disorder (BPD).
Found 8 Approved Drugs for Bipolar Disorder (BPD)
LamoTRIgine
Brand Names
Lamictal, Lamictal ODT, Subvenite
LamoTRIgine
Brand Names
Lamictal, Lamictal ODT, Subvenite
Form: Tablet, Kit, Suspension
Method of administration: Oral
FDA approval date: January 17, 1995
Classification: Anti-epileptic Agent
Lamotrigine is indicated for: Epilepsy — adjunctive therapy in patients aged 2 years and older: Partial-onset seizures. primary generalized tonic-clonic seizures. generalized seizures of Lennox-Gastaut syndrome.
RisperiDONE
Brand Names
Risperdal, Risperdal M-TAB, Risperdal Consta, Perseris, Rykindo, UZEDY
RisperiDONE
Brand Names
Risperdal, Risperdal M-TAB, Risperdal Consta, Perseris, Rykindo, UZEDY
Form: Injection, Tablet, Kit, Solution
Method of administration: Subcutaneous, Oral, Intramuscular
FDA approval date: December 29, 1993
Classification: Atypical Antipsychotic
Risperidone orally disintegrating tablets are atypical antipsychotic indicated for: Treatment of schizophrenia.
Valproic
Generic Name
Valproic
Valproic
Generic Name
Valproic
Form: Capsule, Solution
Method of administration: Oral
FDA approval date: July 01, 1986
Classification: Anti-epileptic Agent
Valproic acid is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic acid is indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures, and adjunctively in patients with multiple seizure types which include absence seizures. Simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs. Complex absence is the term used when other signs are also present. SEE FOR STATEMENT REGARDING FATAL HEPATIC DYSFUNCTION. WARNINGS.
Geodon
Generic Name
Ziprasidone
Geodon
Generic Name
Ziprasidone
Form: Injection, Capsule
Method of administration: Oral, Intramuscular
FDA approval date: December 23, 2003
Classification: Atypical Antipsychotic
Ziprasidone is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see Warnings and Precautions.
Showing 1-5 of 8
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances